Cargando…

Circulating Hypermethylated RASSF1A as a Molecular Biomarker for Diagnosis of Hepatocellular Carcinoma

BACKGROUND: Detection of circulating DNA can be applied for the diagnosis of many malignant neoplasms, including the hepatocellular carcinoma (HCC). The molecular pathogenesis of HCC is complex, involving different genetic and epigenetic alterations, chromosomal aberrations, gene mutations and alter...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mansour, Lamiaa A, Raziky, Maissa El, Mohamed, Amal A, Mahmoud, Enas H, Hamdy, Sherif, El Sayed, Enas H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	West Asia Organization for Cancer Prevention 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373823/ https://www.ncbi.nlm.nih.gov/pubmed/28670882 http://dx.doi.org/10.22034/APJCP.2017.18.6.1637

Ejemplares similares

Identification of RASSF1A promoter hypermethylation as a biomarker for hepatocellular carcinoma
por: Xu, Gang, et al.
Publicado: (2020)

Hypermethylated RASSF1A as Circulating Tumor DNA Marker for Disease Monitoring in Neuroblastoma
por: van Zogchel, Lieke M. J., et al.
Publicado: (2020)

The role of procalcitonin as a guide for the diagnosis, prognosis, and decision of antibiotic therapy for lower respiratory tract infections
por: El-Azeem, Amal Abd, et al.
Publicado: (2013)

Novel Circulating Hypermethylated RASSF1A ddPCR for Liquid Biopsies in Patients With Pediatric Solid Tumors
por: van Zogchel, Lieke M. J., et al.
Publicado: (2021)

Aberrant Promoter Hypermethylation of RASSF Family Members in Merkel Cell Carcinoma
por: Richter, Antje M., et al.
Publicado: (2013)

Prospective Comparison of Hepatocellular Carcinoma Behavior and Survival of Patients who Did or Did not Receive HCV Direct-Acting Antivirals
por: El-Kassas, Mohamed, et al.
Publicado: (2023)

Aberrant Promoter Hypermethylation of RASSF1a and BRCA1 in Circulating Cell-Free Tumor DNA Serves as a Biomarker of Ovarian Carcinoma
por: S, Sandeep Kumar, et al.
Publicado: (2019)

Frequent promoter hypermethylation of RASSF1A and CASP8 in neuroblastoma
por: Lázcoz, Paula, et al.
Publicado: (2006)

Silencing of RASSF3 by DNA Hypermethylation Is Associated with Tumorigenesis in Somatotroph Adenomas
por: Peng, Hu, et al.
Publicado: (2013)

Differential involvement of RASSF2 hypermethylation in breast cancer subtypes and their prognosis
por: Perez-Janices, Noemi, et al.
Publicado: (2015)

RASSF1A hypermethylation in pretreatment serum DNA of neuroblastoma patients: a prognostic marker
por: Misawa, A, et al.
Publicado: (2009)

MicroRNA Signatures for circulating CD133-positive cells in hepatocellular carcinoma with HCV infection
por: Zekri, Abdel-Rahman N., et al.
Publicado: (2018)

Deciphering Promoter Hypermethylation of Genes Encoding for RASSF/Hippo Pathway Reveals the Poor Prognostic Factor of RASSF2 Gene Silencing in Colon Cancers
por: Riffet, Marc, et al.
Publicado: (2021)

RASSF1 Polymorphisms in Cancer
por: Gordon, Marilyn, et al.
Publicado: (2012)

Frequent Promoter Hypermethylation of the APC and RASSF1A Tumour Suppressors in Parathyroid Tumours
por: Juhlin, C. Christofer, et al.
Publicado: (2010)

Regulatory and activated effector T cells in chronic hepatitis C virus: Relation to autoimmunity
por: Fouad, Hanan, et al.
Publicado: (2016)

Clinical Significance of Plasma Osteopontin Level as a Biomarker of Hepatocellular Carcinoma
por: Salem, Mona, et al.
Publicado: (2013)

Detection and monitoring of hypermethylated RASSF1A in serum from patients with metastatic breast cancer
por: Kristiansen, Søren, et al.
Publicado: (2016)

Boosting Akt Pathway by Rupatadine Modulates Th17/Tregs Balance for Attenuation of Isoproterenol-Induced Heart Failure in Rats
por: Ahmed, Lamiaa A., et al.
Publicado: (2021)

Circulating hsa-miR-221 as a possible diagnostic and prognostic biomarker of diabetic nephropathy
por: Abdel-Tawab, Marwa Sayed, et al.
Publicado: (2023)

In Vitro Study on Effect of Zinc Oxide Nanoparticles on the Biological Activities of Croton tiglium L. Seeds Extracts
por: Aboulthana, Wael Mahmoud, et al.
Publicado: (2022)

RASSF2, a potential tumour suppressor, is silenced by CpG island hypermethylation in gastric cancer
por: Endoh, M, et al.
Publicado: (2005)

Frequent DNA Hypermethylation at the RASSF1A and APC Gene Loci in Prostate Cancer Patients of Pakistani Origin
por: Yaqinuddin, Ahmed, et al.
Publicado: (2013)

RASSF1A Promoter Hypermethylation Is a Strong Biomarker of Poor Survival in Patients with Salivary Adenoid Cystic Carcinoma in a Chinese Population
por: Zhang, Chun-Ye, et al.
Publicado: (2014)

Promoter hypermethylation of the tumor-suppressor genes ITIH5, DKK3, and RASSF1A as novel biomarkers for blood-based breast cancer screening
por: Kloten, Vera, et al.
Publicado: (2013)

RASSF1A methylation as a biomarker for detection of colorectal cancer and hepatocellular carcinoma
por: Li, Jian, et al.
Publicado: (2022)

Danhong Injection Alleviates Cardiac Fibrosis via Preventing the Hypermethylation of Rasal1 and Rassf1 in TAC Mice
por: Li, Sinai, et al.
Publicado: (2020)

Human Leukocyte Antigen Class II Alleles (DQB1 and DRB1) as Predictors for Response to Interferon Therapy in HCV Genotype 4
por: Shaker, Olfat, et al.
Publicado: (2013)

Hypermethylated DNA, a circulating biomarker for colorectal cancer detection
por: Rasmussen, Simon Ladefoged, et al.
Publicado: (2017)

The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma
por: Djos, Anna, et al.
Publicado: (2012)

Clinical, laboratory and ultrasonographic findings in Egyptian buffalo (Bubalus bubalis) with caecal and colonic dilatation
por: Khalphallah, Arafat, et al.
Publicado: (2016)

RASSF1A Site-Specific Methylation Hotspots in Cancer and Correlation with RASSF1C and MOAP-1
por: Volodko, Natalia, et al.
Publicado: (2016)

Silymarin enhances the response to oxytetracycline treatment in Oreochromis niloticus experimentally infected with Aeromonas hydrophila
por: Sherif, Ahmed H., et al.
Publicado: (2023)

Serum MicroRNA-21 Negatively Relates to Expression of Programmed Cell Death-4 in Patients with Epithelial Ovarian Cancer
por: Mahmoud, Enas H, et al.
Publicado: (2018)

Ultrasound-Guided Erector Spinae versus Ilioinguinal/Iliohypogastric Block for Postoperative Analgesia in Children Undergoing Inguinal Surgeries
por: El-Emam, El-Sayed M., et al.
Publicado: (2019)

Blind Tracheal Intubation through the Air-Q Intubating Laryngeal Airway in Pediatric Patients: Reevaluation – A Randomized Controlled Trial
por: El-Emam, El-Sayed M., et al.
Publicado: (2019)

Comparative Evaluation of Dexamethasone and Dexmedetomidine as Adjuvants for Bupivacaine in Ultrasound-Guided Infraorbital Nerve Block for Cleft Lip Repair: A Prospective, Randomized, Double-Blind Study
por: El-Emam, El-Sayed M., et al.
Publicado: (2019)

Efficacy of Ultrasound-Guided Caudal Epidural Calcitonin for Patients with Failed Back Surgery Syndrome
por: El-Emam, El-Sayed M., et al.
Publicado: (2020)

Ultrasound-Guided Adductor Canal Block versus Combined Adductor Canal and Infiltration between the Popliteal Artery and the Posterior Capsule of the Knee Block for Osteoarthritis Knee Pain
por: El-Emam, El-Sayed M., et al.
Publicado: (2020)

RASSF6; the Putative Tumor Suppressor of the RASSF Family
por: Iwasa, Hiroaki, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ohgj3uueevv9ug31s6r6caann6